Substance abuse treatment for HIV infected young people: an open pilot trial.

TitleSubstance abuse treatment for HIV infected young people: an open pilot trial.
Publication TypePublication
Year of Publication2014
AuthorsEsposito-Smythers C, Brown LK, Wolff J, Xu J, Thornton S, Tidey J
Corporate AuthorsAdolescent Medicine Trials Network for HIV/AIDS Interventions(ATN 069)
JournalJ Subst Abuse Treat
Date Published2014 Feb
KeywordsAdolescent, Alcoholism, Cognitive Behavioral Therapy, Community Health Services, Feasibility Studies, Female, Follow-Up Studies, HIV Infections, Humans, Male, Marijuana Abuse, Patient Acceptance of Health Care, Pilot Projects, Treatment Outcome, Young Adult

<p>The purpose of this study was to test an integrated cognitive behavioral and contingency management (CBT/CM) intervention for young people living with HIV (YPLH) with an alcohol and/or cannabis use disorder in an open pilot trial. Seventeen participants (ages 18-24) were recruited from three HIV community clinics. Assessments were completed at pre-and post-treatment as well as 3 month follow-up. Eighty percent of participants were retained in the study. Results suggest that the CBT/CM intervention was acceptable, feasible, and could be delivered with fidelity. Further, participants reported significant reductions in alcohol use, withdrawal symptoms, dependence symptoms and related problems, as well as co-occurring depressive symptoms and delinquent behavior across assessment periods. A trend was evident for reductions in marijuana use and related problems. Overall, these preliminary results suggest that a substance abuse CBT/CM intervention tailored to YPLH is acceptable, feasible, and holds promise for symptomatic improvement. Further testing of this type of protocol is warranted.</p>

Alternate JournalJ Subst Abuse Treat
PubMed ID23988190
PubMed Central IDPMC3840092
Grant ListP30AI042853 / AI / NIAID NIH HHS / United States
U01 HD040533 / HD / NICHD NIH HHS / United States
U01 HD040474 / HD / NICHD NIH HHS / United States
U01-HD040533 / HD / NICHD NIH HHS / United States
P30 AI042853 / AI / NIAID NIH HHS / United States